ES2089091T3 - Complejos que contienen acidos s(+)-fenilalcanoicos y acidos alfa-hidroalcanoicos. - Google Patents

Complejos que contienen acidos s(+)-fenilalcanoicos y acidos alfa-hidroalcanoicos.

Info

Publication number
ES2089091T3
ES2089091T3 ES91119524T ES91119524T ES2089091T3 ES 2089091 T3 ES2089091 T3 ES 2089091T3 ES 91119524 T ES91119524 T ES 91119524T ES 91119524 T ES91119524 T ES 91119524T ES 2089091 T3 ES2089091 T3 ES 2089091T3
Authority
ES
Spain
Prior art keywords
acids
phenylalcanoic
hydroalcanoic
alpha
complexes containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91119524T
Other languages
English (en)
Inventor
Henrich Hasko Prof Dr Paradies
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PUETTER MEDICE CHEM PHARM
Original Assignee
PUETTER MEDICE CHEM PHARM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PUETTER MEDICE CHEM PHARM filed Critical PUETTER MEDICE CHEM PHARM
Application granted granted Critical
Publication of ES2089091T3 publication Critical patent/ES2089091T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/132—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Abstract

IBUPROFEN DE S(+), QUE CONTIENEN COMPLEJOS, METODO PARA LA ELABORACION DE ESTOS COMPLEJOS Y PREPARACIONES FARMACEUTICAS QUE CONTENGAN ESTOS COMPLEJOS.
ES91119524T 1990-11-15 1991-11-15 Complejos que contienen acidos s(+)-fenilalcanoicos y acidos alfa-hidroalcanoicos. Expired - Lifetime ES2089091T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4036459 1990-11-15

Publications (1)

Publication Number Publication Date
ES2089091T3 true ES2089091T3 (es) 1996-10-01

Family

ID=6418340

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91119524T Expired - Lifetime ES2089091T3 (es) 1990-11-15 1991-11-15 Complejos que contienen acidos s(+)-fenilalcanoicos y acidos alfa-hidroalcanoicos.

Country Status (17)

Country Link
US (1) US5254728A (es)
EP (1) EP0486964B1 (es)
JP (1) JPH0656738A (es)
KR (1) KR920009767A (es)
CN (1) CN1061405A (es)
AT (1) ATE137487T1 (es)
AU (1) AU643168B2 (es)
BR (1) BR9104995A (es)
CA (1) CA2055682A1 (es)
CS (1) CS346691A3 (es)
DE (2) DE59107762D1 (es)
ES (1) ES2089091T3 (es)
HU (1) HUT59653A (es)
MX (1) MX9102087A (es)
NZ (1) NZ240618A (es)
PL (1) PL292414A1 (es)
ZA (1) ZA919076B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT59692A (en) * 1990-11-15 1992-06-29 Puetter Medice Chem Pharm Process for producing complexes containing s/+/-phenyl-alkanoic acids and aminosugars
TW442287B (en) * 1995-06-13 2001-06-23 American Home Produits Corp Organoleptically acceptable oral pharmaceutical composition comprising the S(+)1,8-diethyl-1-1,3,4,9-tetrahydropyrano[3,4-b] indole-1-acetic acid (Etodolac)
JP4707201B2 (ja) * 1997-02-04 2011-06-22 千寿製薬株式会社 ピリドンカルボン酸の可溶化方法、その可溶化剤および可溶化されたピリドンカルボン酸からなる水性液剤
DE10003757A1 (de) * 2000-01-28 2001-08-02 Knoll Ag Ibuprofen-Wirkstoffzubereitung
EP2214635A1 (en) * 2007-10-19 2010-08-11 Purdue Research Foundation Solid formulations of crystalline compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN166447B (es) * 1985-11-27 1990-05-12 Ethicon Inc
DE3836863A1 (de) * 1988-10-27 1990-05-03 Klosa Josef Fluessige, geloeste antirheumatische arzneizubereitungen
DK0424028T3 (da) * 1989-10-17 1996-01-29 Merck & Co Inc S(+)-ibuprofen-L-aminosyre og S(+)-ibuprofen-D-aminosyre som et forbedret smertestillende middel med fremskyndet indtrædelse
HUT59692A (en) * 1990-11-15 1992-06-29 Puetter Medice Chem Pharm Process for producing complexes containing s/+/-phenyl-alkanoic acids and aminosugars
HUT59656A (en) * 1990-11-15 1992-06-29 Puetter Medice Chem Pharm Process for producing s/+/-phenyl-alkanoic acids and alpha-amino-acids containing complexes and pharmaceutical compositions containing them as active components

Also Published As

Publication number Publication date
PL292414A1 (en) 1992-10-19
EP0486964A3 (en) 1992-12-16
KR920009767A (ko) 1992-06-25
MX9102087A (es) 1992-10-30
NZ240618A (en) 1994-10-26
JPH0656738A (ja) 1994-03-01
HUT59653A (en) 1992-06-29
EP0486964A2 (de) 1992-05-27
ZA919076B (en) 1992-08-26
BR9104995A (pt) 1992-06-23
DE59107762D1 (de) 1996-06-05
CA2055682A1 (en) 1992-05-16
AU8790991A (en) 1992-05-21
AU643168B2 (en) 1993-11-04
US5254728A (en) 1993-10-19
CS346691A3 (en) 1992-06-17
DE4137699A1 (de) 1992-05-27
EP0486964B1 (de) 1996-05-01
CN1061405A (zh) 1992-05-27
HU913573D0 (en) 1992-01-28
ATE137487T1 (de) 1996-05-15

Similar Documents

Publication Publication Date Title
ATE104348T1 (de) O-glycosyliertes ifn-alpha.
FI830100A0 (fi) Nya 6-substituerade s-triazolo /3,4-a/ ftalazinderivat
NO904584D0 (no) Preparater inneholdende hyaluronsyreforbindelser samt fremgangsmaate for fremstilling derav.
DK644388D0 (da) Farmaceutiske praeparater indeholdende 3-hydroxy-smoeresyrederivater
MX9203099A (es) N-heterociclico-n-(4-piperidia)amidas y composiciones farmaceuticas y metodos que emplean dichos compuestos.
NO972391L (no) 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav
NO880179D0 (no) Polymerkomplekser, fremgangsmaate for fremstilling av disse, og farmasoeytiske midler inneholdende disse.
DE3886213T2 (de) Verfahren zur Herstellung von Antioxidant-Zubereitungen.
DK642588D0 (da) Indanderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme
ES2089091T3 (es) Complejos que contienen acidos s(+)-fenilalcanoicos y acidos alfa-hidroalcanoicos.
AU536582B2 (en) Plenylpiperazine derivatives of 1,3,4-oxiadiazolylphends
DK494088D0 (da) 4-oxo-3-quinolincarboxylsyrer, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende disse
ATE5073T1 (de) 5-amino-tetrazol-derivate von retinsaeuren, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
NO873626D0 (no) Fremgangsmaate for fremstilling av frysetoerkede farmasoeytiske preparater av fenylkinolinkarboksylsyrer.
DK493988D0 (da) 4-oxo-3-quinolincarboxylsyrer, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende disse forbindelser
FI890864A0 (fi) Anvaendning av 1,4-dihydropyridinderivat.
NL7702307A (nl) Werkwijze ter bereiding van optisch actieve erythro-15,16-dioxyprosteenzuren en esters daarvan, alsmede farmaceutische preparaten die deze verbindingen als actieve componenten om- vatten.
GR3005231T3 (es)
NO872331D0 (no) Farmasoeytiske preparater for behandling av bakterielle infeksjoner.
SE8202962D0 (sv) 2-metoxifenylestrar av n-substiterade aminosyror, forfarande for deras framstellning och farmaceutiska beredningar innehallande desamma
IT1261959B (it) Composizione farmaceutica atta a migliorare la biodisponibilita' dell'acido eicosapentaenoico e decosaesaenoico
NO830819L (no) Farmasoeytiske preparater for behandling av huden.
ATE98292T1 (de) Verfahren zur herstellung von antioxidantzubereitungen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 486964

Country of ref document: ES

FG2A Definitive protection

Ref document number: 486964

Country of ref document: ES